Our Services
Medical Information
Helpful Resources
Published on: 3/11/2026
Still bloated most days despite diet changes? For many with IBS with diarrhea or suspected SIBO, Xifaxan (rifaximin) is a gut-targeted, FDA approved antibiotic that reduces bloating, gas, and urgent stools when taken as 550 mg three times daily for 14 days, and some may need a repeat course; there are several factors to consider, so see the complete details below.
Because it reduces bacterial overgrowth but does not cure the root cause, long-term relief usually requires medically guided steps like a short-term low FODMAP plan, motility support, and stress-focused therapies, plus evaluation for other causes and urgent care for red flags such as weight loss or bleeding; the full next-step checklist is outlined below.
If you feel bloated most days—tight stomach, pressure after eating, excess gas, unpredictable bowel habits—you're not imagining it. Chronic bloating is common, but that doesn't mean it's normal.
For many people, especially those diagnosed with IBS with diarrhea (IBS-D) or suspected small intestinal bacterial overgrowth (SIBO), the answer may involve a prescription medication called Xifaxan (rifaximin). But medication alone is rarely the full story.
Let's walk through what's really happening in your gut, how Xifaxan works, and what medically supported next steps can help you feel better long term.
Occasional bloating after a large meal is normal. Ongoing bloating that:
… may point to an imbalance in gut bacteria or IBS-D.
One common but often overlooked cause is small intestinal bacterial overgrowth (SIBO). This happens when bacteria that normally live in the colon grow in the small intestine, where they don't belong.
When these bacteria ferment food—especially carbohydrates—they produce gas. That gas stretches the intestine and causes:
If this sounds familiar, a structured evaluation is important.
If you're experiencing persistent discomfort and want to understand what might be causing it, try this free bloated stomach symptom checker to get personalized insights before your next doctor visit.
Xifaxan (rifaximin) is a prescription antibiotic that stays mostly in the gut rather than entering the bloodstream. That's important because it targets bacteria locally while causing fewer whole-body side effects than many other antibiotics.
It is FDA-approved for:
In IBS-D, Xifaxan is typically prescribed as:
Some patients may need repeat treatment if symptoms return.
Unlike broad-spectrum antibiotics, Xifaxan works mainly inside the intestines. It:
Clinical studies show that many people with IBS-D experience:
However, it's important to understand something realistic:
Xifaxan reduces bacterial overgrowth, but it does not permanently "cure" IBS or SIBO.
That's why next steps matter.
Bloating can return after Xifaxan if underlying drivers aren't addressed. Common causes of relapse include:
This doesn't mean the treatment failed. It means the gut environment still needs support.
To get the best long-term results, many gastroenterologists recommend combining Xifaxan with supportive strategies.
A low-FODMAP diet is often recommended short term. FODMAPs are fermentable carbohydrates that feed gut bacteria.
Reducing them can:
Important: This diet is meant to be temporary and structured. Long-term restriction without guidance can negatively affect gut diversity.
Work with a healthcare professional if possible.
If food and bacteria linger too long in the small intestine, overgrowth can return.
Ways doctors may support motility:
Movement matters more than most people realize.
The gut and brain are directly connected through the gut-brain axis.
Chronic stress can:
Evidence-based tools include:
This is not "in your head." It's biology.
If bloating persists despite treatment, your doctor may evaluate for:
Persistent, worsening, or unexplained symptoms should always be assessed medically.
Most chronic bloating is related to functional gut disorders like IBS. However, you should speak to a doctor urgently if you experience:
These symptoms need medical evaluation to rule out serious conditions.
Do not ignore red flags.
Xifaxan is generally well tolerated. Because it stays mostly in the gut, systemic side effects are limited.
Possible side effects include:
As with any antibiotic, there is a small risk of altering normal gut bacteria balance. This is one reason treatment should be supervised by a physician.
Never self-prescribe antibiotics.
You may want to speak with a doctor about Xifaxan if you have:
It is not typically used for constipation-predominant IBS unless specifically indicated.
During the 14-day course of Xifaxan:
It's important to complete the full prescribed regimen.
After treatment, your doctor may reassess symptoms in 4–6 weeks.
If you're still bloated after trying diet changes, probiotics, or over-the-counter remedies, it may be time to look deeper.
For many people with IBS-D or SIBO, Xifaxan is a well-studied, targeted treatment that can reduce bloating and improve quality of life. But medication works best when paired with:
Chronic bloating is uncomfortable, frustrating, and disruptive—but it is treatable.
If you're unsure what's driving your symptoms, consider starting with a structured evaluation like this free bloated stomach symptom checker, then take those results to your healthcare provider.
Most importantly, speak to a doctor about any persistent, severe, or concerning symptoms—especially if they include red flags like weight loss, bleeding, fever, or severe pain.
You don't have to live in a constant state of discomfort. With the right medical guidance and a targeted approach, your gut can improve.
(References)
* Pimentel M, Lembo A, Chey WD, et al. Rifaximin: a new look at an old drug. *Expert Rev Gastroenterol Hepatol*. 2018 Sep;12(9):839-847. doi:10.1080/17474124.2018.1507963. PMID: 30048107.
* Ford AC, Quigley EMM, Lacy BE, et al. Systematic review and meta-analysis of rifaximin for irritable bowel syndrome with diarrhea. *J Clin Gastroenterol*. 2016 Jul;50(6):528-536. doi:10.1097/MCG.0000000000000570. PMID: 27040448.
* Ghoshal UC, Srivastava D, Pandey V, et al. Rifaximin and Its Efficacy in Reducing Bloating and Improving Global Symptoms in Patients with Irritable Bowel Syndrome and Small Intestinal Bacterial Overgrowth. *J Clin Gastroenterol*. 2020 Feb;54(2):173-179. doi:10.1097/MCG.0000000000001229. PMID: 32015091.
* Dukowicz AC, Lacy BE, Levine GM. Management of small intestinal bacterial overgrowth: a comprehensive review. *Gastroenterol Hepatol (N Y)*. 2020 Mar;16(3 Suppl 1):1-10. PMID: 32103482.
* Rej A, Macqueen G, Pieroni P, et al. Role of diet in the treatment of irritable bowel syndrome. *J Can Assoc Gastroenterol*. 2018 Jun 29;1(3):144-152. doi:10.1093/jcag/gwy003. PMID: 29519183.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.